ATAI Insider Trading Activity and SEC Form 4 Filings
ATAI insider trading summary
Over the past 12 months, insiders at AtaiBeckley Inc. (ATAI) reported 6 sales worth $1.7M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $1.7M.
Latest ATAI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Robert Hershberg | Insider | Sell | $496K (100,000 @ $4.96) |
| Jun 26, 2026 | Gerd Kochendoerfer | Chief Operating Officer | Sell | $250K (50,000 @ $5.00) |
| Jun 25, 2026 | Kevin James Craig | Chief Medical Officer | Sell | $192K (42,579 @ $4.51) |
| Apr 20, 2026 | Kevin James Craig | Chief Medical Officer | Sell | $213K (42,579 @ $5.00) |
| Mar 20, 2026 | Kevin James Craig | Chief Medical Officer | Sell | $355K (100,000 @ $3.55) |
| Jan 2, 2026 | Cosmo Feilding-Mellen | Insider | Sell | $154K (39,594 @ $3.90) |
| Aug 14, 2025 | Apeiron Investment Group Ltd. | Insider | Buy | $19.0M (8,675,799 @ $2.19) |
| Aug 14, 2025 | Christian Angermayer | Insider | Buy | $19.0M (8,675,799 @ $2.19) |
| Mar 24, 2025 | Apeiron Investment Group Ltd. | Insider | Buy | $2.5M (1,800,000 @ $1.40) |
| Mar 24, 2025 | Christian Angermayer | Insider | Buy | $2.5M (1,800,000 @ $1.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.